DR.Chip Biotechnology Incorporation announced earnings results for the third quarter ended September 30, 2018. For the third quarter, the company announced sales was TWD 26.945 million compared to TWD 2.599 million a year ago. Operating loss was TWD 6.895 million compared to TWD 5.861 million a year ago. Net loss was TWD 5.730 million compared to TWD 5.286 million a year ago. Basic loss per share was TWD 0.12 compared to TWD 0.14 a year ago. For the nine months, sales was TWD 39.925 million compared to TWD 10.140 million a year ago. Operating loss was TWD 19.520 million compared to TWD 15.713 million a year ago. Net loss was TWD 17.176 million compared to TWD 16.250 million a year ago. Basic loss per share was TWD 0.38 compared to TWD 0.42 a year ago.